Closed
Save

Notice of Intent to Sole Source One Lambda, Inc. for Instrument Repair and Rebuild

Health & Human Services (HHS) > NIH
FFP
est. $11K – $102K

This opportunity is closed

The response deadline has passed. Review the details for future reference or to track similar opportunities.

Quick Brief

The Department of Health and Human Services is procuring specific HLA typing and antibody screening reagents from One Lambda, Inc. for the National Institutes of Health's Human Leukocyte Antigen Laboratory. These reagents are essential for clinical diagnostic testing and have been validated for accuracy and precision, making them critical for timely patient care.

Generated 30d ago

Scope & Requirements

The work involves providing HLA typing and antibody screening reagents necessary for clinical diagnostic testing in the Human Leukocyte Antigen Laboratory.

Contract Details

Contract Typei
FFP
Estimated Value
est. $11K – $102K
Similar contracts award $11K$105K (median $31K, 6,018 awards)Within typical range
Incumbent Contractor
One Lambda, Inc.
NAICS Codes
Place of Performance
Bethesda, MD, USA

Agency & Contact

Contracting Organization

Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-Agency
National Institutes of Health

Point of Contact

John A. Smith
Contracting Officer
(202) 555-0100

Key Dates

Published2mo ago
Mar 23, 2026
Last Updated2mo ago
Mar 23, 2026
Response Due1mo ago
Apr 27, 2026

Description

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to One Lambda, Inc., located at 22801 Roscoe Blvd, West Hills, CA 91304, on a firm fixed price sole source award basis to provide specific HLA typing and antibody screening reagents. The HLA Lab currently uses these reagents to test our patients. The reagents provided by One Lambda have been previously tested in the lab and provide a greater ability to resolve testing ambiguities than other vendors tested. All validation testing has been completed for these reagents so there is laboratory documentation available to confirm the accuracy and precision of these reagents. A change in vendors/reagents would require extensive validation and would take approximately 2 months. This would greatly impact the ability of the HLA Lab to provide timely results. The function of the Human Leukocyte Antigen Laboratory (HLA) of the Department of Transfusion Medicine, CC is to (1) provide clinical diagnostic laboratory testing for patients in the Clinical Center to facilitate possible transplant or enrollment into an appropriate protocol for the patient’s particular condition; (2) to conduct clinical consultations for Clinical Center physicians in the management of patient care in regards to potential transplant scenarios; (3) to maintain accreditation through various accrediting agencies in order to provide quality results (4) to conduct research in the development of new diagnostic laboratory tests (5) to facilitate the support and development of protocols which involve HLA testing and the implications for patient care. The proposed vendor, One Lambda, is the sole provider of the LABType, LABScreen, and Secore kits. No other vendors would be suitable. These exact reagents are not available from any other vendor and have been quality control tested to validate their performance. To change vendors for a similar reagent kit would require extensive testing and validation of the new reagents which would impact patient care. Huda Malik Contracting ., SUITE 503L (No Street Address

2) BETHESDA, MD 20892 USA to this opportunity.

Get matched to contracts like this daily

Free AI-powered contract matching for your business.